NYSE:AIM

Aim Immunotech Stock Forecast

etoro logo Buy AIM
*Your capital is at risk
$0.284
+0.0206 (+7.83%)
At Close: Aug 05, 2026

Should you buy AIM stock?

Last updated:

Based on market data through , StockInvest.us rates AIM ImmunoTech Inc. (AIM) as a Buy Candidate with a technical score of 1.26 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation.

  • Buy signal since
  • Price since signal Flat 0.00%
  • 3-month trend forecast Down 21.18%
  • Buy Candidate 1.26
AI Analysis AI Analysis of AIM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AIM to Watchlist?
Some Reasons Why To Add AIM:
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong return on equity of 261.8%
  • Highly efficient cash conversion (103% FCF/OCF ratio)
PDF

High volatility in AIM ImmunoTech Inc. stock price on Wednesday which ended trading at $0.284
(Market data through Aug 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Aug 05, 2026

The AIM ImmunoTech Inc. stock price gained 7.83% on the last trading day (Wednesday, 5th Aug 2026), rising from $0.263 to $0.284. During the last trading day the stock fluctuated 19.32% from a day low at $0.251 to a day high of $0.300. The price has been going up and down for this period, and there has been a 11.92% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $1.64 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.222 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.18% during the next 3 months and, with a 90% probability hold a price between $0.175 and $0.593 at the end of this 3-month period.

AIM Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 30, 2026, and so far it has risen 20.68%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The AIM ImmunoTech Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.291. On a fall, the stock will find some support from the short-term average at $0.254. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for AIM ImmunoTech Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.253 and $0.244. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AIM ImmunoTech Inc. finds support just below today's level at $0.253. If this is broken, then the next support from accumulated volume will be at $0.244 and $0.233.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0485 between high and low, or 19.32%. For the last week, the stock has had daily average volatility of 11.28%.

Our recommended stop-loss: $0.273 (-3.90%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (AIM) For The Upcoming Trading Day Of Thursday 6th

For the upcoming trading day on Thursday, 6th we expect AIM ImmunoTech Inc. to open at $0.278, and during the day (based on 14 day Average True Range), to move between $0.267 and $0.300, which gives a possible trading interval of +/-$0.0335 (+/-12.56%) up or down from last closing price. If AIM ImmunoTech Inc. takes out the full calculated possible swing range there will be an estimated 12.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.296 (4.44%) than the support at $0.253 (10.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

AIM ImmunoTech Inc. will release earnings BMO on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.170. We will update the financials statements for AIM ImmunoTech Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.20% in the first trading day after earnings release.

Is AIM ImmunoTech Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.257 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 6, 2026 - $0.278 ( 1.94%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AIM Performance

Trading levels for AIM

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.327 15.16%
R2 0.308 8.63%
R1 0.297 4.59%
Price 0.284
S1 0.260 -8.47%
S2 0.248 -12.51%
S3 0.230 -19.04%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.338 19.15%
R2 0.308 8.50%
R1 0.296 4.44%
Price 0.284
S1 0.253 -10.75%
S2 0.244 -14.14%
S3 0.233 -17.95%

FAQ

What is the symbol for AIM ImmunoTech Inc. Stock and on which exchange is it traded?
The symbol for AIM ImmunoTech Inc. is AIM and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell AIM ImmunoTech Inc. Stock?
Based on market data through Aug 05, 2026, StockInvest.us rates AIM ImmunoTech Inc. (AIM) as a Buy Candidate with a technical score of 1.26 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation. Since the Buy signal began on Aug 05, 2026, the price has remained flat. The current 3-month trend forecast projects a fall of 21.18%.

How to buy AIM ImmunoTech Inc. Stock?
AIM ImmunoTech Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AIM ImmunoTech Inc. Stock.

What's the current price of AIM ImmunoTech Inc. Stock?
As of the end of day on the Aug 05, 2026, the price of an AIM ImmunoTech Inc. (AIM) share was $0.284.

What is the 52-week high and low for AIM ImmunoTech Inc. Stock?
The 52-week high for AIM ImmunoTech Inc. Stock is $2.91 and the 52-week low is $0.210.

What is the market capitalization of AIM ImmunoTech Inc. Stock?
As of the Aug 05, 2026, the market capitalization of AIM ImmunoTech Inc. is 965.244K.

When is the next earnings date for AIM ImmunoTech Inc.?
The upcoming earnings date for AIM ImmunoTech Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT AIM IMMUNOTECH INC.
AIM ImmunoTech
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, n...
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE